Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Chemotherapy Induced Neutropenia
- Colony Stimulating Factors Adverse Reaction
- Cost-effectiveness Analysis
- Epithelial Ovarian Cancer
- Febrile Neutropenia, Drug-Induced
- Granulocyte Colony Stimulating Factor
- Overall Survival
- Progression Free Survival
- Quality of Life
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04101760
- Collaborators
- Beijing Hospital
- China-Japan Friendship Hospital
- The Sixth Medical Center of PLA General Hospital
- Seventh Medical Center of PLA Army General Hospital
- Investigators
- Principal Investigator: Lei Li, M.D. Peking Union Medical College Hospital